𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial

✍ Scribed by Stefano Cascinu; Eva Galizia; Roberto Labianca; Francesco Ferraù; Francesca Pucci; Rosa Rita Silva; Gabriele Luppi; Giordano Domenico Beretta; Rossana Berardi; Mario Scartozzi

Publisher
Springer
Year
2010
Tongue
English
Weight
296 KB
Volume
68
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of 5-fluorouracil, doxo
A phase II trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma
✍ Susan G. Arbuck; Yusuf Silk Md; Harold O. Douglass Jr.; Hector Nava; Youcef M. R 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 2 views

To determine the feasibility and toxicity of combining leucovorin (CF) with a 5fluorouracil(5-FU) combination chemotherapy regimen currently accepted by many as standard treatment for gastric cancer, CF (500 mg/m') was administered in combination with the Georgetown S-FU, doxorubicin, and mitomycin

A randomized Phase III trial of etoposid
A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma
✍ Fikri İçli; İsmail Çelik; Faruk Aykan; Aytuǧ Üner; Ahmet Demirkazik; Ahmet Özet; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. Gastric carcinoma is a substantial health problem in Turkey, and the majority of patients present with inoperable disease. The aim of this randomized trial was to assess the activity of 5-fluorouracil versus etoposide when combined with epirubicin plus cisplatin in patients with adv